Vivo Capital Surplus Fund VIII, L.P. - Insider Non-Derivative Transactions at IMPEL PHARMACEUTICALS INC (IMPL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 19, 2023, Vivo Capital Surplus Fund VIII, L.P.'s relationship to IMPEL PHARMACEUTICALS INC (IMPL) is TenPercentOwner, and currently has 2,029,495 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other IMPL insiders.
Data Source: SEC.
Vivo Capital Surplus Fund VIII, L.P. - Insider Non-Derivative Transactions of IMPL Common Stock
Vivo Capital Surplus Fund VIII, L.P. - Insider Non-Derivative Transactions at IMPL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 20, 2023 | Sell -- (Common Stock) | 28632 | 0.08 | 280294 |
| Dec 20, 2023 | Sell -- (Common Stock) | 208657 | 0.08 | 2029495 |
| Dec 19, 2023 | Sell -- (Common Stock) | 28682 | 0.11 | 308926 |
| Dec 19, 2023 | Sell -- (Common Stock) | 209029 | 0.11 | 2238152 |
| Dec 16, 2023 | Sell -- (Common Stock) | 12066 | 0.29 | 337608 |
| Dec 16, 2023 | Sell -- (Common Stock) | 87934 | 0.29 | 2447181 |